Ftse Mib
33.345,28
0,48%
DAX
18.334,87
0,71%
S&P 500
5.482,87
0,09%
NASDAQ
17.858,68
0,30%
Bitcoin
61.455,95
-0,25%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Entasis Therapeutics Holdings Inc (ETTX) Entasis Therapeutics Holdings Inc (ETTX) Notizie

ETTX

Entasis Therapeutics (ETTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ETTX
DataOraFonteTitoloSimboloCompagnia
12/10/202214:30GlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
21/07/202223:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202223:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202223:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202223:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202222:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202223:05Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202223:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202222:49Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202214:35Business WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
07/06/202215:05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
25/05/202200:36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
23/05/202222:19Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
23/05/202222:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
02/05/202222:06Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/04/202222:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/04/202212:16TipRanksEntasis Therapeutics Holdings (ETTX) Gets a Hold Rating from H.C. WainwrightNASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/03/202213:32TipRanksWedbush Downgrades Entasis Therapeutics Holdings (ETTX) to HoldNASDAQ:ETTXEntasis Therapeutics Holdings Inc
04/03/202212:27TipRanksAnalyst Explains Why They Downgraded Their Rating on Entasis Therapeutics Holdings (ETTX)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
03/03/202222:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
25/02/202223:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
14/02/202217:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
19/10/202115:00GlobeNewswire Inc.Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK TrialNASDAQ:ETTXEntasis Therapeutics Holdings Inc
28/08/202100:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
06/08/202112:12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
02/08/202122:40Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
19/07/202122:06Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202122:17Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/05/202117:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
05/05/202122:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ETTX

La tua Cronologia

BIT
P20VU5
NLBNPIT20VU5 20240621 6.5
USOTC
BPIRF
Piraeus Financial (PK)
BIT
P21B08
NLBNPIT21B08 20351221 12...
LSE
ZM49
Saudi.araba 61u
BIT
P1UOU8
NLBNPIT1UOU8 20241220 30
BIT
P1UYR3
NLBNPIT1UYR3 20991231 12...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network